In the last completed session, Aurobindo Pharma Ltd. closed +0.86% with futures open interest moving -0.2%. Positioning is neutral — neither side is decisively adding or unwinding right now. The stock's option PCR sits at 0.59, indicating heavy call-side writing — option dealers see resistance overhead. Max-pain strike at ₹1,460 sits 1.4% above the current price, a mild magnet near expiry.
There have been no notable bulk or block deals from FIIs, mutual funds, or insurance companies in Aurobindo Pharma Ltd. over the last 30 sessions.
Putting it together, the smart-money picture for Aurobindo Pharma Ltd. lacks a clear directional bias.
Fundamental ratios sourced from public market data, refreshed periodically; verify against company filings before relying on them.
| Call OI (writers) | Strike | Put OI (writers) |
|---|---|---|
| 1320 | ||
|
IV 76%
Δ 0.68
θ -2.1
ν 1
|
1340 |
IV 26%
Δ -0.13
θ -0.4
ν 1
|
| 1360 |
IV 25%
Δ -0.17
θ -0.4
ν 1
|
|
|
IV 23%
Δ 0.79
θ -0.7
ν 1
|
1380 |
IV 24%
Δ -0.23
θ -0.5
ν 1
|
|
IV 27%
Δ 0.69
θ -0.9
ν 1
|
1400 S |
IV 24%
Δ -0.29
θ -0.5
ν 1
|
|
IV 27%
Δ 0.62
θ -0.9
ν 1
|
1420 |
IV 23%
Δ -0.37
θ -0.5
ν 1
|
|
IV 26%
Δ 0.54
θ -0.9
ν 2
|
1440 |
IV 23%
Δ -0.46
θ -0.5
ν 2
|
|
IV 26%
Δ 0.47
θ -0.9
ν 2
|
1460 MP |
IV 22%
Δ -0.54
θ -0.5
ν 2
|
|
IV 26%
Δ 0.39
θ -0.8
ν 2
|
1480 |
IV 23%
Δ -0.63
θ -0.5
ν 1
|
|
IV 26%
Δ 0.32
θ -0.8
ν 1
|
1500 |
IV 22%
Δ -0.71
θ -0.4
ν 1
|
|
IV 26%
Δ 0.26
θ -0.7
ν 1
|
1520 |
IV 20%
Δ -0.81
θ -0.2
ν 1
|
|
IV 27%
Δ 0.20
θ -0.6
ν 1
|
1540 |
IV 31%
Δ -0.75
θ -0.5
ν 1
|
|
IV 27%
Δ 0.16
θ -0.5
ν 1
|
1560 |
IV 14%
Δ -0.98
θ +0.2
ν 0
|